Brief: Huakang Biomedical Says Trading In Shares Will Be Halted
Jan 5 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* TRADING IN SHARES WILL BE HALTED WITH EFFECT FROM 1:00
P.M. ON 5
JANUARY 2023
* TRADING HALT PENDING RELEASE OF INSIDE INFORMATION
ANNOUNCEMENT
IN RELATION TO DISCLOSEABLE TRANSACTION OF CO
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology